Video content on TikTok related to hair disorders lacks reliability, even when the videos are created by dermatologists or other physicians. Still, physician-made videos were more reliable than non-physician-made videos. Citing sources and providing additional reading options are possible actions that could be taken to improve video content on hair disorders.
“TikTok is a video-focused social network with 1.4 billion monthly users,” explained Dr Betty Nguyen (University of Miami, FL, USA). “It is one of the fastest growing social media platforms in the world and has been used to spread dermatologic information.” Studies reporting on this information found that the video content had major shortcomings, even when videos were made by physicians [1,2].
The current study investigated the characteristics of TikTok’s most viewed videos on alopecia [3]. The authors looked at the type of hair condition being discussed, who made the videos, the content of the videos, and the reliability of the content. The top 25 most viewed videos for the top 8 most popular hair disorders were included in the analysis (n=200).
Videos on alopecia areata (43 million views), traction alopecia (24 million views), and trichotillomania (10 million views) were the most frequently viewed diagnoses. Patients were responsible for 64.5% of the most popular video content. Board-certified dermatologists (9.8%), self-proclaimed hair experts (8.7%), and other medical practitioners (4.4%) were other sources of popular videos. The video content was mostly about personal experiences (54.6%). However, educational videos (32.8%), hair care tips (18.6%), and product reviews (13.7%) were also common topics in the most popular videos. The educational videos covered treatment options (70.0%), aetiology (58.3%), diagnosis (15.0%), and nutrition (8.3%).
Dr Nguyen and co-investigators assessed the reliability of the content using the DISCERN score. This instrument rates the reliability and quality of online health information on a scale from 1 to 5; 1 being ‘low quality with serious or extensive shortcomings’, and 5 being ‘high quality with minimal shortcomings’. Although the videos made by physicians had higher DISCERN scores than the videos of non-physicians (2.22 vs 1.52; P<0.0001), the scores indicate that even the physician-made content had serious shortcomings. “Citing sources, discussing the risks and benefits of treatment options, and providing options for additional reading could be areas for improvement of the videos,” argued Dr Nguyen.
- Zheng DX, et al. Pediatr Dermatol. 2021;38(1):336–338.
- Rehman R, et al. JAAD Int. 2021;5:98–100.
- Nguyen B, et al. Alopecia content on TikTok: A cross-sectional analysis. Session Hair disorders 1, WCD 2023, 3-8 July, Singapore, Singapore.
Posted on
« Spesolimab appears successful in hidradenitis suppurativa Next Article
Can ritlecitinib deliver long-term efficacy in alopecia areata? »
Table of Contents: WCD 2023
Featured articles
Atopic Dermatitis
Rocatinlimab delivers efficacy and safety in atopic dermatitis
Head-to-head: paraffin- versus ceramide-based moisturiser for paediatric AD
Novel JAK1 inhibitor for patients with atopic dermatitis
Can lebrikizumab maintain response rates in atopic dermatitis?
Most patients with AD on dupilumab stick with this drug long-term
Psoriasis
Botulinum toxin A might provide efficacious treatment option for nail psoriasis
POETYK PSO-1 and 2: Long-term efficacy results of deucravacitinib in plaque psoriasis
Encouraging results for first oral IL-23 receptor antagonist in plaque psoriasis
Subcutaneous spesolimab for GPP flare prevention
Knocking out psoriasis with high-dose risankizumab?
Deucravacitinib versus other systemic therapies in Asian patients with psoriasis
Hair Disorders
Patients with AA report high long-term regrowth rates with baricitinib
Can ritlecitinib deliver long-term efficacy in alopecia areata?
TikTok videos on hair disorders lack reliability
Hidradenitis, Acne, and Rosacea
Spesolimab appears successful in hidradenitis suppurativa
Promising results for paroxetine in rosacea
Novel PPARγ modulator reduces acne manifestations
Microencapsulated benzoyl peroxide shifts skin microbiome in rosacea
Other Skin Conditions and Teledermatology
OLYMPIA 2: Positive results for nemolizumab in prurigo nodularis
PRFM or PRP therapy for trophic ulcers due to leprosy?
Large teledermatology project in a remote island in Eastern Indonesia
Can AI-driven teledermatology increase access to healthcare in rural African settings?
Oleogel-S10 shows long-term efficacy and safety in dystrophic epidermolysis bullosa
Picosecond alexandrite laser safe and effective in benign pigmentary disorders
Gentamicin improves symptoms in paediatric Nagashima-type palmoplantar keratosis
Related Articles
Can lebrikizumab maintain response rates in atopic dermatitis?
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com